SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VALGIMIGLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.648
AS - Asia 2.011
EU - Europa 831
SA - Sud America 340
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 41
OC - Oceania 2
Totale 6.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.544
SG - Singapore 767
CN - Cina 488
BR - Brasile 255
VN - Vietnam 243
DE - Germania 152
HK - Hong Kong 152
UA - Ucraina 134
IT - Italia 122
GB - Regno Unito 110
BD - Bangladesh 109
TR - Turchia 68
FI - Finlandia 67
CA - Canada 52
FR - Francia 52
RU - Federazione Russa 52
SE - Svezia 44
IN - India 43
JP - Giappone 43
MX - Messico 31
AR - Argentina 26
ID - Indonesia 24
PL - Polonia 23
ZA - Sudafrica 20
CO - Colombia 16
EC - Ecuador 14
IQ - Iraq 14
NL - Olanda 12
PK - Pakistan 12
BE - Belgio 11
ES - Italia 11
VE - Venezuela 11
IE - Irlanda 10
AL - Albania 7
CR - Costa Rica 7
SA - Arabia Saudita 6
CL - Cile 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
UY - Uruguay 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
PY - Paraguay 4
AT - Austria 3
EG - Egitto 3
JO - Giordania 3
OM - Oman 3
PR - Porto Rico 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
TN - Tunisia 2
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.874
Salva come PNG Salva come JPEG
Città #
Singapore 437
Ashburn 436
Woodbridge 290
Fairfield 286
San Jose 194
Santa Clara 181
Beijing 176
Ann Arbor 164
Chandler 153
Hong Kong 149
Houston 141
Jacksonville 134
Seattle 119
New York 112
Wilmington 107
Ho Chi Minh City 82
Los Angeles 69
Cambridge 65
Council Bluffs 53
Hanoi 51
Dallas 46
Princeton 43
Tokyo 42
Izmir 38
Helsinki 37
Nanjing 37
Lauterbourg 31
Buffalo 29
San Diego 29
Bremen 25
Milan 25
São Paulo 25
Munich 24
Boardman 22
Mexico City 22
Shanghai 22
Phoenix 21
Toronto 20
Warsaw 20
Chicago 19
Jakarta 17
Orem 17
Falkenstein 16
Brooklyn 15
Shenyang 14
Denver 13
Jiaxing 13
Redwood City 13
London 12
Montreal 12
Tianjin 12
Brussels 11
Changsha 11
Dearborn 11
Nanchang 11
Bologna 10
Johannesburg 10
Baghdad 9
Da Nang 9
Frankfurt am Main 9
Jinan 9
Moscow 9
Rio de Janeiro 9
Atlanta 8
Boston 8
Charlotte 8
Haiphong 8
Hefei 8
Ninh Bình 8
Philadelphia 8
San Francisco 8
Stockholm 8
Washington 8
Chennai 7
Dublin 7
Ferrara 7
Leawood 7
Manchester 7
Nuremberg 7
Rome 7
San José 7
San Mateo 7
Auburn Hills 6
Columbus 6
Curitiba 6
Dhaka 6
Hangzhou 6
Newark 6
Norwalk 6
Poplar 6
Shenzhen 6
Amsterdam 5
Ankara 5
Dong Ket 5
Falls Church 5
Mountain View 5
Piscataway 5
The Dalles 5
Thái Nguyên 5
Zhengzhou 5
Totale 4.490
Salva come PNG Salva come JPEG
Nome #
Poor response to clopidogrel: current and future options for its management 307
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 272
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 268
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 247
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 243
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 243
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 227
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 211
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 206
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 197
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry 197
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 197
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 195
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 193
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 186
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients 183
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 181
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 178
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 177
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial 175
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 168
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial 168
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Insights Into the STRATEGY Study 168
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial 166
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 166
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 164
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 158
High-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare metal stent in acute myocardial infarction (STRATEGY) study 151
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial 149
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 145
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 132
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 123
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 123
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 121
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 103
Stable angina pectoris 97
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 93
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies 86
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 67
null 61
null 61
Totale 6.953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022437 0 51 54 20 23 14 35 27 14 33 49 117
2022/2023362 46 5 19 49 68 58 9 29 47 8 16 8
2023/2024275 25 26 11 8 17 81 10 13 5 8 5 66
2024/2025951 10 26 87 28 126 120 20 19 181 100 133 101
2025/20262.902 284 148 253 336 373 183 220 179 294 311 182 139
2026/2027178 103 75 0 0 0 0 0 0 0 0 0 0
Totale 6.953